Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Recursion Pharmaceuticals Stock a Buy Now?

TheMotleyFool

0 0

Is Recursion Pharmaceuticals Stock a Buy Now?: https://g.foolcdn.com/editorial/images/750193/person-sitting-at-a-desk-looking-at-two-monitors.jpg

It has been a tumultuous year for the clinical-stage biotech Recursion Pharmaceuticals (NASDAQ: RXRX). Earlier this year, the company's shares skyrocketed after it announced a partnership with the tech giant Nvidia, but Recursion has since given up all these gains -- and then some. As of this writing, the company's stock is down by 8% since the year started.

Still, Recursion has a bold project in place (more on that below), and if it pans out, the company could deliver outsize returns to its shareholders. Does that make Recursion Pharmaceuticals' shares a buy today?